EGFR and lung adenocarcinoma: In our study, we confirmed the in vitro cytotoxic efficacy of fluvastatin and pitavastatin in combination with erlotinib on EGFR TKI resistant human lung adenocarcinoma cell lines A549, Calu6 and H1993.